Refine by
Bioinformatics Research Articles & Analysis
28 news found
"The application of next-generation sequencing has revolutionized the field of lncRNA research, allowing us to uncover a vast repertoire of these enigmatic molecules and delineate their functional roles," said the Director of Bioinformatics at CD Genomics. ...
Utilizing state-of-the-art sequencing technology and rigorous experimental protocols, the company ensures the accuracy and repeatability of data, enhancing the reliability and significance of research results. Bioinformatics Analysis Support: CD Genomics' services extend beyond data provision. The company also offers comprehensive ...
The upgraded TCR-Seq technology leverages advanced sequencing techniques and cutting-edge bioinformatics analysis, enabling researchers to delve deeper into the nuances of immune responses. ...
CD Genomics, a global leader in genomic and bioinformatics solutions, is pleased to announce the official launch of its Viral Metagenomic Sequencing service. This state-of-the-art offering represents a major advancement in the field of pathogen research and promises to provide unparalleled insights into viral communities. ...
CD Genomics, a trailblazing genomics and bioinformatics services provider, is delighted to announce the launch of the Long Amplicon Analysis (LAA) service, a mature genomic research method that promises to revolutionize the field. ...
This approach is poised to revolutionize the field of drug discovery by offering researchers an efficient and cost-effective solution for identifying promising drug candidates. ...
Their team of seasoned experts leverages advanced bioinformatics analysis to generate comprehensive and comprehensible data. ...
Differential Expression Analysis: The service includes robust bioinformatics analysis, allowing researchers to identify differentially expressed exosomal transcripts with statistical rigor. ...
Bioinformatics-Analysis is a subdivision of CD Genomics, providing reliable next-generation and third-generation high-throughput sequencing data analysis, database construction, and other related data analysis services utilizing comprehensive technology. ...
Based on rich experience in genomic analysis, CD Genomics has developed a specialized platform for targeted sequencing of cancer-related genes to accelerate research on disease pathogenesis, disease identification, biomarker discovery, targeted drug development, etc. The company has optimized its Cancer Hotspot Panel Sequencing service to meet the most challenging ...
The company is pleased to announce the launch of the CRISPR off-target analysis service to help researchers optimize the CRISPR system, reduce off-target rates, and further explore genetic information related to human health. ...
CD ComputaBio, a reliable computational biology service provider in New York, is committed to assisting research and trials, as well as providing access to the latest software, technologies, and expertise with competitive prices and fast turnarounds for researchers. The company has announced the introduction of the PyMOL software, a powerful utility for studying ...
Do you want to help usher in advanced cancer diagnostics and monitoring to improve patient quality of life and survival? SAGA Diagnostics AB is seeking a talented and highly motivated Bioinformatics Scientist with strong interest in advancing our mission to revolutionize cancer diagnostics through proprietary ultrasensitive technologies that measure circulating tumor DNA (ctDNA) in ...
In February, the company announced strategic research/bioinformatics appointments in the form of Dr. Christian Roghi as Director of Microbiome Solutions in the UK; and Dr. ...
(NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced the publication of a scientific paper titled “Exodus: Sequencing-based Pipeline for Quantification of Pooled Variants” in the journal, ...
ByBiomX
CD Genomics is a genomics service company with a good reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. To help scientific researchers better understand fungal biodiversity, physiology, metabolism and function, CD Genomics MicrobioSeq has launched the fungal whole-genome de novo sequencing service. ...
” In an article published in CPT: Pharmacometrics & Systems Pharmacology, the research groups at Molecular Health and University of Florida discuss the principles and future potential of applying a reverse translational strategy in drug development to investigate drug effects at the molecular level, understand causality, and anticipate prevalence of adverse effects. ...
The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in ...
CD Genomics is a leading services company committed to providing global customers with the most comprehensive analytic services, including a broad range of microbial genomic solutions to support research and development. The company announced microbiome profiling services, alongside bioinformatic analysis technology to help researchers understand ...
These characteristics are part of complex control loops and require reliable research tools. CD Genomics has developed powerful epigenetic research and analysis technologies covering sample preparation, sequencing, quantitative PCR, functional analysis experiments, and bioinformatics tools. ...